secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGENUS INC (AGEN)
CIK:        0001098972
Form:       8-K
Filed at:   2024-06-17T23:59:59+00:00
Accession:  0000950170-24-074231
Event type: leadership
Sentiment:  positive
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Agenus appoints Jennifer Buell to Board of Directors, stresses BOT/BAL BLA filing
--------------------------------------------------------------------------------

- Dr. Jennifer Buell appointed to Agenus Board effective June 11, 2024.
- Buell remains President/CEO of MiNK Therapeutics and Chairman of Agenus Executive Council.
- Priority is to guide BOT/BAL program toward Biologics License Application submission this year.
- Brings 27+ years biopharma experience; previously served as President & COO of Agenus.
- No committee assignments; previously granted options for 37,500 shares (2023 and 2024).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1098972/000095017024074231/0000950170-24-074231-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1098972/000095017024074231/agen-20240611.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-074231

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer